Datulaita, Amor .
HRN: 02-88-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2025
CEFTRIAXONE 1G (VIAL)
09/29/2025
10/05/2025
IV
2g
Od
Cap Mr
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes